Advertisement
Screener

Personalis, Inc. (PSNL) Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount

2.8 / 5 stars · 68/120 Roast Me

Personalis, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount

Personalis, Inc. (PSNL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $27.90 million as of 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Additional Disclosure

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-04

  • 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $27.90M.
  • 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $29.20M.
  • 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.20M.
  • 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.80M.
Period endShare-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
2026-06-30$27.90M
10-Q · filed 2026-08-04
2026-03-31$29.20M
10-Q · filed 2026-05-07
2025-12-31$14.20M
10-K · filed 2026-02-26
2025-09-30$14.80M
10-Q · filed 2025-11-04
2025-06-30$13.80M
10-Q · filed 2025-08-05
2025-03-31$14.30M
10-Q · filed 2025-05-06
2024-12-31$6.50M
10-K · filed 2025-02-27
2024-09-30$7.50M
10-Q · filed 2024-11-06
2024-06-30$6.70M
10-Q · filed 2024-08-07
2024-03-31$7.90M
10-Q · filed 2024-05-08
2023-12-31$7.20M
10-K · filed 2024-02-28
2023-09-30$8.70M
10-Q · filed 2023-11-07
2023-06-30$10.10M
10-Q · filed 2023-08-08
2023-03-31$11.60M
10-Q · filed 2023-05-03
2022-12-31$10.30M
10-K · filed 2023-02-23
2022-09-30$14.80M
10-Q · filed 2022-11-02
2022-06-30$14.30M
10-Q · filed 2022-08-03
2022-03-31$15.90M
10-Q · filed 2022-05-04
2021-12-31$18.10M
10-K · filed 2022-02-24
2021-09-30$19.40M
10-Q · filed 2021-11-04
2021-06-30$19.00M
10-Q · filed 2021-08-04
2021-03-31$13.40M
10-Q · filed 2021-05-05
2020-12-31$13.30M
10-K · filed 2021-02-25
2020-09-30$11.40M
10-Q · filed 2020-11-05
2020-06-30$12.00M
10-Q · filed 2020-08-06
2020-03-31$10.50M
10-Q · filed 2020-05-07
2019-12-31$9.60M
10-K · filed 2020-03-25
2019-09-30$10.20M
10-Q · filed 2019-11-13
2019-06-30$10.30M
10-Q · filed 2019-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
CareDx, Inc. (CDNA)United States$3.174B13.21
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64